These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 425315)
1. Susceptibility of irradiated mice to inoculation with two influenza virus strains. Prahoveanu E; Boeru V; Teodosiu O; Petrescu A Virologie; 1979; 30(1):29-35. PubMed ID: 425315 [No Abstract] [Full Text] [Related]
2. Experimental studies on influenza A2 virus infection after peroral inoculation. Sidorova LA; Alekseyeva AK Acta Virol; 1973 Jul; 17(4):293-7. PubMed ID: 4148208 [No Abstract] [Full Text] [Related]
3. Resistance of mice immunized per os with A2 influenza virus to intranasal challenge with a pathogenic strain. Sidorova LA; Alekseyeva AK Acta Virol; 1973 Jul; 17(4):298-304. PubMed ID: 4148209 [No Abstract] [Full Text] [Related]
4. The influence of endogenous hypocorticism on the replication of influenza virus in the mouse lungs and the production of specific antibodies. Semenkov VF; Levina LV; Lavrov VF; Ageeva ON Acta Virol; 1990 Feb; 34(1):37-43. PubMed ID: 1975723 [TBL] [Abstract][Full Text] [Related]
5. Maternal-infant transfer of influenza-specific immunity in the mouse. Reuman PD; Paganini CM; Ayoub EM; Small PA J Immunol; 1983 Feb; 130(2):932-6. PubMed ID: 6848601 [TBL] [Abstract][Full Text] [Related]
6. Humoral and cell-mediated immune response to influenza virus. I. Experiments in mice. Semkow R; Loza-Tulimowska M; Wilczyński J; Brydak L; Zgorzelska K Acta Microbiol Pol; 1982; 31(2):185-94. PubMed ID: 6188341 [No Abstract] [Full Text] [Related]
7. [Biological relations of selected influenza virus strains adapted to mouse lungs. I. H3N2 influenza virus study]. Nabi N; Maksimova-Todorova V; Gegova G; Manolova N Acta Microbiol Bulg; 1980; 6():42-7. PubMed ID: 7340409 [No Abstract] [Full Text] [Related]
8. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice. Epstein SL; Lo CY; Misplon JA; Lawson CM; Hendrickson BA; Max EE; Subbarao K J Immunol; 1997 Feb; 158(3):1222-30. PubMed ID: 9013963 [TBL] [Abstract][Full Text] [Related]
9. Interferon and humoral immune response in experimental influenza. I. Infection with virus unadapted to the mouse. Szalaty H; Szulc B Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):503-8. PubMed ID: 749803 [TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin-A antibodies in upper airway secretions may inhibit intranasal influenza virus replication in mice but not protect against clinical illness. Bizanov G; Janakova L; Knapstad SE; Karlstad T; Bakke H; Haugen IL; Haugan A; Samdal HH; Haneberg B Scand J Immunol; 2005 Jun; 61(6):503-10. PubMed ID: 15963044 [TBL] [Abstract][Full Text] [Related]
11. [Effect of parenteral vaccination on the characteristics of experimental influenza in mice]. Nikitina LE Tr Inst Im Pastera; 1979; 52():155-60. PubMed ID: 550540 [No Abstract] [Full Text] [Related]
12. [Studies of the adaptation of influenza viruses to lowered temperatures of replication. II. Studies in vivo]. Brydak L; Sadowski W Med Dosw Mikrobiol; 1990; 42(1-2):50-3. PubMed ID: 1964991 [TBL] [Abstract][Full Text] [Related]
13. [Persistent infection in mice caused by the administration of a "defective" population of the influenza virus]. Shcherbinskaia AM Mikrobiol Zh (1978); 1983; 45(5):71-5. PubMed ID: 6400783 [No Abstract] [Full Text] [Related]
14. Nasal mucosal administration of chitin microparticles boosts innate immunity against influenza A virus in the local pulmonary tissue. Baaten BJ; Clarke B; Strong P; Hou S Vaccine; 2010 Jun; 28(25):4130-7. PubMed ID: 20433805 [TBL] [Abstract][Full Text] [Related]
15. Humoral and cell-mediated immune response to influenza virus. II. Experiments in ferrets. Semkow R; Loza-Tulimowska M; Brydak L; Zgorzelska K; Wilczyński J; Sadowski W Acta Microbiol Pol; 1982; 31(2):195-202. PubMed ID: 6188342 [No Abstract] [Full Text] [Related]
16. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Liew FY; Russell SM; Appleyard G; Brand CM; Beale J Eur J Immunol; 1984 Apr; 14(4):350-6. PubMed ID: 6609824 [TBL] [Abstract][Full Text] [Related]
17. Clearance of antibody and complement in serum after challenge of mice previously vaccinated or infected with influenza virus. Semkow R; Wilczyński J Acta Virol; 1979 May; 23(3):253-6. PubMed ID: 41439 [TBL] [Abstract][Full Text] [Related]
18. Suppression of immunity to influenza virus infection in the respiratory tract following sleep disturbance. Brown R; Pang G; Husband AJ; King MG Reg Immunol; 1989; 2(5):321-5. PubMed ID: 2562046 [TBL] [Abstract][Full Text] [Related]
19. [Reproduction and immunogenic properties of recombinant and parent strains of influenza virus]. Zgorzelska K; Semkow R Med Dosw Mikrobiol; 1981; 33(2):115-8. PubMed ID: 6170847 [No Abstract] [Full Text] [Related]
20. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]